Sort by
Items per page

Send to

Choose Destination

Search results

Items: 36


Association between histopathological alterations and diarrhea severity in acute intestinal graft-versus-host disease.

da Costa LNG, Costa-Lima C, de Meirelles LR, Carvalho RB, Colella MP, Aranha FJP, Vigorito AC, De Paula EV.

Medicine (Baltimore). 2018 May;97(19):e0600. doi: 10.1097/MD.0000000000010600.


Synergistic effect of KIR ligands missing and cytomegalovirus reactivation in improving outcomes of haematopoietic stem cell transplantation from HLA-matched sibling donor for treatment of myeloid malignancies.

Cardozo DM, Marangon AV, da Silva RF, Aranha FJP, Visentainer JEL, Bonon SHA, Costa SCB, Miranda ECM, de Souza CA, Guimarães F.

Hum Immunol. 2016 Oct;77(10):861-868. doi: 10.1016/j.humimm.2016.07.003. Epub 2016 Jul 6.


Pretransplant β2-Microglobulin Is Associated with the Risk of Acute Graft-versus-Host-Disease after Allogeneic Hematopoietic Cell Transplant.

Costa-Lima C, Miranda ECM, Colella MP, Aranha FJP, de Souza CA, Vigorito AC, De Paula EV.

Biol Blood Marrow Transplant. 2016 Jul;22(7):1329-1332. doi: 10.1016/j.bbmt.2016.03.024. Epub 2016 Apr 1.


Comparison of diagnostic tests in distinct well-defined conditions related to dry eye disease.

Alves M, Reinach PS, Paula JS, Vellasco e Cruz AA, Bachette L, Faustino J, Aranha FP, Vigorito A, de Souza CA, Rocha EM.

PLoS One. 2014 May 21;9(5):e97921. doi: 10.1371/journal.pone.0097921. eCollection 2014.


Cytomegalovirus (CMV) genotype in allogeneic hematopoietic stem cell transplantation.

Dieamant DC, Bonon SH, Peres RM, Costa CR, Albuquerque DM, Miranda EC, Aranha FJ, Oliveira-Duarte G, Fernandes VC, De Souza CA, Costa SC, Vigorito AC.

BMC Infect Dis. 2013 Jul 10;13:310. doi: 10.1186/1471-2334-13-310.


Functional evaluation indicates physical losses after hematopoietic stem cell transplantation.

de Souza CV, Miranda EC, Garcia C Jr, Aranha FJ, de Souza CA, Vigorito AC.

Rev Bras Hematol Hemoter. 2012;34(5):345-51. doi: 10.5581/1516-8484.20120090.


Association between human leukocyte antigens and graft-versus-host disease occurrence after allogenic hematopoietic stem cell transplantation.

Cardozo DM, Lieber SR, Marques SB, Aranha FJ, Vigorito AC, Souza CA, Visentainer JE.

Sao Paulo Med J. 2012;130(4):219-24.


Time-course of sFlt-1 and VEGF-A release in neutropenic patients with sepsis and septic shock: a prospective study.

Alves BE, Montalvao SA, Aranha FJ, Lorand-Metze I, De Souza CA, Annichino-Bizzacchi JM, De Paula EV.

J Transl Med. 2011 Mar 3;9:23. doi: 10.1186/1479-5876-9-23.


Importance of killer immunoglobulin-like receptors in allogeneic hematopoietic stem cell transplantation.

Franceschi DS, de Souza CA, Aranha FJ, Cardozo DM, Sell AM, Visentainer JE.

Rev Bras Hematol Hemoter. 2011;33(2):126-30. doi: 10.5581/1516-8484.20110033.


Surveillance of active human cytomegalovirus infection in hematopoietic stem cell transplantation (HLA sibling identical donor): search for optimal cutoff value by real-time PCR.

Peres RM, Costa CR, Andrade PD, Bonon SH, Albuquerque DM, de Oliveira C, Vigorito AC, Aranha FJ, de Souza CA, Costa SC.

BMC Infect Dis. 2010 Jun 1;10:147. doi: 10.1186/1471-2334-10-147.


Imbalances in serum angiopoietin concentrations are early predictors of septic shock development in patients with post chemotherapy febrile neutropenia.

Alves BE, Montalvao SA, Aranha FJ, Siegl TF, Souza CA, Lorand-Metze I, Annichino-Bizzacchi JM, De Paula EV.

BMC Infect Dis. 2010 May 28;10:143. doi: 10.1186/1471-2334-10-143.


Brazilian experience using high-dose sequential chemotherapy followed by autologous hematopoietic stem cell transplantation for relapsed or refractory Hodgkin lymphoma.

Duarte BK, Valente I, Vigorito AC, Aranha FJ, Oliveira-Duarte G, Miranda EC, Lorand-Metze I, Pagnano KB, Delamain M, Marques Junior JF, Brandalise SR, Nucci M, De Souza CA.

Clin Lymphoma Myeloma. 2009 Dec;9(6):449-54. doi: 10.3816/CLM.2009.n.088.


Cluster randomized clinical trial (ISRCTN23732000) to evaluate the effectiveness of a diagnosis recognition and treatment guide for depressive disorders in primary care.

Tsuji SR, Atallah AN, Aranha FC, Tonhom AP, Siqueira AC Jr, Matos D.

J Eval Clin Pract. 2009 Feb;15(1):222-5. doi: 10.1111/j.1365-2753.2008.00978.x. No abstract available.


[Opinions and attitudes regarding sexuality: Brazilian national research, 2005].

Paiva V, Aranha F, Bastos FI; Grupo de Estudos em População, Sexualidade e Aids.

Rev Saude Publica. 2008 Jun;42 Suppl 1:54-64. Portuguese.


IL2 and TNFA gene polymorphisms and the risk of graft-versus-host disease after allogeneic haematopoietic stem cell transplantation.

Viel DO, Tsuneto LT, Sossai CR, Lieber SR, Marques SB, Vigorito AC, Aranha FJ, de Brito Eid KA, Oliveira GB, Miranda EC, de Souza CA, Visentainer JE.

Scand J Immunol. 2007 Dec;66(6):703-10.


[Association between HLA and leukemia in a mixed Brazilian population].

Barion LA, Tsuneto LT, Testa GV, Lieber SR, Persoli LB, Marques SB, Vigorito AC, Aranha FJ, Eid KA, Oliveira GB, Miranda EC, Souza CA, Visentainer JE.

Rev Assoc Med Bras (1992). 2007 May-Jun;53(3):252-6. Portuguese.


Clinical impact of oral health indexes in dental extraction of hemophilic patients.

Correa ME, Annicchino-Bizzacchi JM, Jorge J Jr, Paes de Almeida O, Ozelo MC, Aranha FJ, Lourdes Barjas-Castro M.

J Oral Maxillofac Surg. 2006 May;64(5):785-8.


Frontline therapy with early intensification and autologous stem cell transplantation versus conventional chemotherapy in unselected high-risk, aggressive non-Hodgkin's lymphoma patients: a prospective randomized GEMOH report.

Baldissera RC, Nucci M, Vigorito AC, Maiolino A, Simões BP, Lorand-Metze I, Aranha FJ, Miranda EC, Pagnano KB, Ruiz MA, Moraes AA, De Souza CA.

Acta Haematol. 2006;115(1-2):15-21.


Platelet glycoprotein Ibalpha polymorphisms modulate the risk for myocardial infarction.

Ozelo MC, Origa AF, Aranha FJ, Mansur AP, Annichino-Bizzacchi JM, Costa FF, Pollak ES, Arruda VR.

Thromb Haemost. 2004 Aug;92(2):384-6.


Serum cytokine levels and acute graft-versus-host disease after HLA-identical hematopoietic stem cell transplantation.

Visentainer JE, Lieber SR, Persoli LB, Vigorito AC, Aranha FJ, de Brito Eid KA, Oliveira GB, Miranda EC, de Souza CA.

Exp Hematol. 2003 Nov;31(11):1044-50.


Addition of low-dose busulfan to cyclophosphamide in aplastic anemia patients prior to allogeneic bone marrow transplantation to reduce rejection.

Dulley FL, Vigorito AC, Aranha FJ, Sturaro D, Ruiz MA, Saboya R, Macedo MC, Da Silva RL, Chamone DA, Mehta J, Bacigalupo A, De Souza CA.

Bone Marrow Transplant. 2004 Jan;33(1):9-13.


The availability of full match sibling donors and feasibility of allogeneic bone marrow transplantation in Brazil.

Eid KA, Miranda EC, Vigorito AC, Aranha FJ, Oliveira GB, De Souza CA.

Braz J Med Biol Res. 2003 Mar;36(3):315-21. Epub 2003 Mar 7.


Addition of exogenous cytokines in mixed lymphocyte culture for selecting related donors for bone marrow transplantation.

Visentainer JE, Lieber SR, Persoli Lg, Vigorito AC, Aranha FJ, Souza Cr.

Sao Paulo Med J. 2002 Nov 1;120(6):175-9. Epub 2003 Jan 22.


Immature reticulocytes as an early predictor of engraftment in autologous and allogeneic bone marrow transplantation.

Noronha JF, De Souza CA, Vigorito AC, Aranha FJ, Zulli R, Miranda EC, Grotto HZ.

Clin Lab Haematol. 2003 Feb;25(1):47-54.


A randomized, multicenter study of G-CSF starting on day +1 vs day +5 after autologous peripheral blood progenitor cell transplantation.

de Azevedo AM, Nucci M, Maiolino A, Vigorito AC, Simões BP, Aranha FJ, Tabak DG, Voltarelli J, de Souza CA.

Bone Marrow Transplant. 2002 May;29(9):745-51.


Correlation of mixed lymphocyte culture with chronic graft-versus-host disease following allogeneic stem cell transplantation.

Visentainer JE, Lieber SR, Persoli LB, de Souza Lima SC, Vigorito AC, Aranha FJ, Eid KA, Oliveira GB, Miranda EC, de Souza CA.

Braz J Med Biol Res. 2002 May;35(5):567-72.


The influence of the graft monocytes in the outcome of allogeneic bone marrow transplantation.

Aranha FJ, Vigorito AC, De Sousa CA, Oliveira GB, Zulli R, Lorand-Metze I.

Haematologica. 2002 Feb;87(2):219-20.


Apoptosis-regulating proteins and prognosis in diffuse large B cell non-Hodgkin's lymphomas.

Pagnano KB, Silva MD, Vassallo J, Aranha FJ, Saad ST.

Acta Haematol. 2002;107(1):29-34.


A randomized, prospective comparison of allogeneic bone marrow and peripheral blood progenitor cell transplantation in the treatment of hematologic malignancies: an update.

Vigorito AC, Marques Júnior JF, Aranha FJ, Oliveira GB, Miranda EC, De Souza CA.

Haematologica. 2001 Jun;86(6):665-6. No abstract available.


Early total white blood cell recovery is a predictor of low number of apheresis and good CD34(+) cell yield.

Marques JF, Vigorito AC, Aranha FJ, Lorand-Metze I, Miranda EC, Lima Filho EC, Valbonesi M, Santini G, De Souza CA.

Transfus Sci. 2000 Oct;23(2):91-100.


A randomised, prospective comparison of allogeneic bone marrow and peripheral blood progenitor cell transplantation in the treatment of haematological malignancies.

Vigorito AC, Azevedo WM, Marques JF, Azevedo AM, Eid KA, Aranha FJ, Lorand-Metze I, Oliveira GB, Correa ME, Reis AR, Miranda EC, de Souza CA.

Bone Marrow Transplant. 1998 Dec;22(12):1145-51.


Treatment of prolymphocytic leukemia with cladribine.

Lorand-Metze I, Oliveira GB, Aranha FJ.

Ann Hematol. 1998 Feb;76(2):85-6.


Allogeneic transplantation for hematological malignancies using rho G-CSF mobilized blood stem cells.

Azevedo WM, Aranha FJ, Gouvea JV, Vigorito AC, Marques JF, Eid KA, Azevedo AM, Barbosa KB, Souza CA.

Bone Marrow Transplant. 1996 Mar;17 Suppl 2:S54-5. No abstract available.


Allogeneic transplantation with blood stem cells mobilized by rhG-CSF for hematological malignancies.

Azevedo WM, Aranha FJ, Gouvea JV, Vigorito AC, Marques JF Jr, Eid KA, Azevedo AM, Souza CA.

Bone Marrow Transplant. 1995 Nov;16(5):647-53.


Peripheral T-cell lymphoma in HIV-positive patients.

Vassallo J, Andrade LA, Pedro RJ, Aranha FJ.

Rev Paul Med. 1993 May-Jun;111(3):427-9.


Supplemental Content

Loading ...
Support Center